JAVMA news
Racing to save humans through animal research
Veterinary researchers are improving our understanding of the SARS-CoV-2 virus, interspecies transmission, and a host of other public and animal…
AVMA news
Research on aging a natural fit for One Health approach
With today’s technological advancements, researchers are calling for a concerted effort to gather big data on aging dogs to benefit not only…
JAVMA news
In Short
Osteosarcoma is genetically similar in dogs and human children, according to a study published July 19 in the journal Communications Biology by Tufts…
JAVMA news
Research symposium inspires with one-health success stories
The 2016 Merial–National Institutes of Health National Veterinary Scholars Symposium took place July 28-31 at The Ohio State University.
JAVMA news
Therapy dogs have mixed results for childhood cancer patients, parents
Visits with therapy dogs have mixed results for childhood cancer patients and their parents, according to a study.
JAVMA news
Research awards presented
The AVMA and American Veterinary Medical Foundation conferred awards on Dr. Henry J. Baker and Dr. Deborah W. Knapp for advancing veterinary research
JAVMA news
Veterinarian won Nobel for immunology research
The only veterinarian to win a Nobel Prize, Dr. Peter C. Doherty was a state veterinary officer in Australia before embarking on a career in…
JAVMA news
COVID vaccine an immunological moonshot
Developing and distributing a vaccine for a novel coronavirus that has killed more than a million people globally has the potential of becoming the…
JAVMA news
Finding a future for osteosarcoma patients
Ana M. Cilursu, MD, lost three Rottweilers in a row to bone cancer.
JAVMA news
Vaccine holds promise for treating osteosarcoma in dogs
Veterinarians in the audience wanted to know when they could get their hands on the new treatment. Dr. Sue Ettinger, a veterinary oncologist, had…
JAVMA news
A glimmer of hope for a fatal feline disease
Controlling risk factors for feline infectious peritonitis is difficult, while new antiviral drugs show great promise